By Ella Devereux and Ben Clover2026-09-10T06:01:00
The medicines regulator should be allowed to fine AI companies that put patients at risk, its chief executive has said.
With a HSJ subscription you’ll unlock:
Already a subscriber? Sign into your account here
Part of HSJ Information Ltd. The White Chapel Building, 1st Floor, 10 Whitechapel High Street, London, E1 8QS. Registered in England and Wales. Company registration 2530185
Site powered by Webvision Cloud